Option chain shows key data for American Lithium Corp Warrants (11/05/2024)'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for American Lithium Corp Warrants (11/05/2024).

American Lithium Corp Warrants (11/05/2024) (OTC:AMRLF) Stock, Option Chain

American Lithium Corp Warrants (11/05/2024)

News

Financing

IESC

IES Announced That It Has Amended And Restated Its Existing Credit And Security Agreement, Increasing The Commitment Amount Of The Revolving Credit Facility To $300M From $150M And Extending The Maturity Date To January 21, 2030 While Expanding The Size Of The Lending Group

Deutsche Bank analyst Steve Powers maintains PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) with a Buy and lowers the price target from $184 to $178.

Price Target

Analyst Ratings

Deutsche Bank Maintains Buy on PepsiCo, Lowers Price Target to $178

Macquarie analyst Tim Nollen maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Outperform and raises the price target from $965 to $1150.

NFLX

Macquarie Maintains Outperform on Netflix, Raises Price Target to $1150

Deutsche Bank analyst Stephen Powers maintains Mondelez International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>) with a Hold and lowers the price target from $67 to $62.

MDLZ

Deutsche Bank Maintains Hold on Mondelez International, Lowers Price Target to $62

RVSN

Rail Vision Announced The Signing Of A Binding Memorandum Of Understanding With Sujan Ventures, A Division Of The Esteemed Sujan Group To The Indian Rail Industry

Northland Capital Markets analyst Michael Latimore maintains Gorilla Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) with a Outperform and raises the price target from $13 to $18.

GRRR

Northland Capital Markets Maintains Outperform on Gorilla Tech Gr, Raises Price Target to $18

Barclays analyst Jason Goldberg maintains Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Underweight and raises the price target from $59 to $61.

ZION

Barclays Maintains Underweight on Zions Bancorp, Raises Price Target to $61

Northland Capital Markets analyst Gus Richard reiterates Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Outperform and raises the price target from $144 to $160.

Reiteration

Northland Capital Markets Reiterates Outperform on Seagate Tech Hldgs, Raises Price Target to $160

REKR

Rekor Systems' AI-Powered Scout Platform Secures Role In $13M New Jersey Public Safety Upgrade

WIIM

AGYS

Agilysys shares are trading lower after the company reported worse-than-expected Q3 sales results and issued FY25 revenue guidance below estimates.

HC Wainwright &amp; Co. analyst Robert Burns maintains Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) with a Buy and raises the price target from $17 to $21.

REPL

HC Wainwright & Co. Maintains Buy on Replimune Group, Raises Price Target to $21

Barclays analyst Nicholas Campanella maintains Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) with a Overweight and lowers the price target from $71 to $69.

Barclays Maintains Overweight on Xcel Energy, Lowers Price Target to $69

Barclays analyst Benjamin Budish maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Overweight and raises the price target from $95 to $96.

SCHW

Barclays Maintains Overweight on Charles Schwab, Raises Price Target to $96

COHR

Coherent Announces The Launch Of New Pin-hole Array Biochips For Medical Diagnostics, With A Focus On Gene Sequencing Applications

Super Group (SGHC) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) (the "Group" or "Super Group"), the parent company of Betway, a leading online sports betting and gaming business and Spin, the multi-brand online casino, today provided an update on its preliminary, unaudited fourth quarter and full-year 2024 performance.
The Group is pleased to announce that Q4 2024 is expected to be its strongest ever ex-US quarter with Total Revenue of ~€486 million and Adjusted EBITDA, a non-GAAP financial measure, of between €125 million and €130 million. During the quarter the Group projects to have set a number of new monthly ex-US records, with December being particularly impressive, achieving new highs for deposits and Total Revenue.
For the full-year, the Group expects to have surpassed its previously issued ex-US guidance targets of Total Revenue of €1.60 billion and Adjusted EBITDA of greater than €360 million.
New ex-US records were also expected to have been achieved in 2024 for both Total Revenue and Adjusted EBITDA, with Total Revenue growing by ~18% to ~€1.66 billion and Adjusted EBITDA growing by more than 50%, anticipated to be between €387 million and €392 million, a margin of greater than 23%.
The developing U.S. business is also anticipated to have delivered new records in the fourth quarter – October was an all-time high for Total Revenue, which was subsequently surpassed in both November and December. The expected Q4 2024 investment into the U.S. business is ~€11 million, which would bring the total investment for the year to ~€61 million. Given the reduced footprint and sole focus on iGaming in the U.S., this investment is expected to reduce materially in 2025.

Guidance

SGHC

Super Group Expects Q4 Revenue Of ~€486M Vs €404.65M Est, FY24 Revenue Of ~€1.66B Vs ~€1.613B Est

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) from Neutral to Neutral.

AGEN

HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral

3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) reported better-than-expected fourth-quarter 2024 results and initiated 2025 <a href="https://www.benzinga.com/25/01/43096753/3m-reports-strong-q4-results-anticipates-growth-in-2025-with-improved-organic-sales-outlook">guidance on Tuesday.</a>
The company reported net sales of $6.01 billion, a slight increase of 0.13% year-over-year. Adjusted net sales totaled $5.808 billion, up 2.2% YoY, beating the consensus of $5.781 billion. Adjusted EPS was $1.68, down 2% YoY, beating the consensus of $1.66.
3M said it anticipates adjusted total sales growth of 0.5% to 1.5%, driven by adjusted organic sales growth of 2% to 3%. The company projects adjusted EPS in the range of $7.60 to $7.90 versus consensus of $7.78.
3M shares gained 4.2% to close at $146.89 on Tuesday.
These analysts made changes to their price targets on 3M following earnings announcement.
<ul>
<li>Wells Fargo analyst Joe O&#8217;Dea upgraded the rating for 3M from Equal-Weight to Overweight and raised the price target from $140 to $170.</li>
<li>JP Morgan analyst Stephen Tusa maintained 3M with an Overweight rating and raised the price target from $162 to $165.</li>
<li>Barclays analyst Julian Mitchell maintained the stock with an Overweight rating and boosted the price target from $161 to $165.</li>
</ul>

Considering buying MMM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="494" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22073705/image-151-1024x494.png" alt="" class="wp-image-744610" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22073705/image-151-1024x494.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22073705/image-151-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22073705/image-151-768x370.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22073705/image-151.png 1093w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43123084/top-3-health-care-stocks-that-could-blast-off-this-quarter">Top 3 Health Care Stocks That Could Blast Off This Quarter</a></li>
</ul>

Earnings

Markets

Trading Ideas

3M Analysts Raise Their Forecasts After Better-Than-Expected Q4 Results

SeaStar Medical Holding Announces That Mayo Clinic Is Now Cleared To Enroll Subjects In The Company's Neutralize-aki Pivotal Trial, Increasing The Number Of Activated Sites To 15

Barclays analyst Nicholas Campanella maintains PPL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPL#NYSE">PPL</a>) with a Equal-Weight and lowers the price target from $34 to $33.

Barclays Maintains Equal-Weight on PPL, Lowers Price Target to $33

OFG Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OFG#NYSE">OFG</a>) reported quarterly earnings of $1.09 per share which beat the analyst consensus estimate of $0.96 by 13.54 percent. This is a 11.22 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $149.138 million which beat the analyst consensus estimate of $147.401 million by 1.18 percent. This is a 3.93 percent increase over sales of $143.500 million the same period last year.

Comments

American Lithium Corp Warrants (11/05/2024)

American Lithium Corp Warrants (11/05/2024) (AMRLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga